More trials meet norms under Indian tiered approval system amid calls for increased transparency
This article was originally published in SRA
Executive Summary
India's health ministry has indicated that 14 of the ongoing clinical trials that were part of the remaining 107 studies that needed to be re-evaluated following a court directive have met all relevant aspects of safety and efficacy, and has recommended that these be allowed to continue in the country.